ReviewFrontiers in immunology2026

Reprogramming CAR T cells across genetic, epigenetic, metabolic and microenvironmental axes to improve efficacy and safety in cancer and autoimmune disease.

Marc ScherlingerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.